Skip to main content

Table 6 Comparison of SSRS, FACT-L, CD-RISC- 10, FHI, and medical costs among patients with 4 FT potential categories of cancer (N = 421)

From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients

Variables

C1

C2

C3

C4

F/H

P

N = 82

N = 33

N = 150

N = 156

Mean (SD)/M (Q1,Q3)

Mean (SD)M (Q1,Q3)

Mean (SD)M (Q1,Q3)

Mean (SD)M (Q1,Q3)

FACT-L

91.12 (18.04)

79.21 (8.75)

80.73 (17.52)

71.13 (19.33)

23.243**

 < 0.001

PWB

19.5 (16.75,23)

21 (18.5,23)

17 (13,21)

14.5 (11,18)

63.633*

 < 0.001

SWB

17 (14.75,20)

9 (8,12.5)

15 (12,17.25)

15 (13,17)

57.493*

 < 0.001

EWB

19.5 (10,20)

19 (17.5,19)

14 (7,19)

9 (4,15)

63.742*

 < 0.001

FWB

14 (9,19)

6 (3,9)

11 (7,15)

9 (6,12.75)

56.205*

 < 0.001

ACL

26 (20.75,29.25)

24 (21.5,28)

23 (19,28)

23 (17,27)

11.393*

0.010

SSRS

31.5 (28,35.25)

35 (30,38)

30 (28,35)

30 (27,34)

14.193*

0.003

Subjective Support

10 (8,10.25)

9 (8,10)

10 (8,10)

10 (8,11)

6.258*

0.200

Objective Support

17 (14,20)

19 (16.5,21)

16 (14,19)

15 (12,18)

25.00*

 < 0.001

Utilization of Social Support

6 (4,7)

7 (4.5,9)

5 (4,7.25)

5 (4,7)

6.731*

0.081

CD-RISC- 10

26.5 (18.75,31)

7 (3,13)

20 (12,25)

18 (11,23.75)

74.872*

 < 0.001

Total Hospital Expenses

40000 (20000,86250)

150000 (8000,200000)

53000 (22000,15000)

90000 (40000, 200000)

31.531*

 < 0.001

Out-of-Pocket Expenses

120000 (0,23000)

60000 (25000,105000)

15000 (1125,26000)

15000 (7250,27500)

32.239*

 < 0.001

Cost of Outsourcing Drugs

0 (0,10000)

8000 (320,52000)

1000 (0,16000)

6750 (0,34000)

20.679*

 < 0.001

Board and Lodging Expenses

2700 (1387.5,6000)

6300 (4800,11400)

3550 (1100,9000)

4450 (1800,8362.5)

16.156*

0.001

Total Transportation Cost

1275 (415,3000)

6000 (3000,16500)

2280 (600,4400)

2000 (1090,6000)

37.479*

 < 0.001

Total Nutrition Cost

400 (0,4250)

0 (0,5000)

215 (0,5000)

0 (0,3000)

0.628*

0.653

  1. *stands for H test
  2. **stands for F test